FDA backs covid boosters for seniors

  • The timing of the FDA decision was highly unusual given that the agency typically takes action before the CDC convenes its own experts.
    The timing of the FDA decision was highly unusual given that the agency typically takes action before the CDC convenes its own experts.
    The United States moved a step closer Wednesday to offering booster doses of Pfizer’s covid-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administratio...

    Premium Content is available to subscribers only. Please login here to access content or go here to purchase a subscription.